Bone density, microarchitecture, and tissue quality after long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine. Güerri-Fernández, R., Molina-Morant, D., Villar-Garcı́a, Judit, Herrera, S., González-Mena, A., Guelar, A., Trenchs-Rodrı́guez, Marta, Dı́ez-Pérez, Adolfo, & Knobel, H. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75(3):322–327, LWW, 2017. bibtex @article{guerri2017bone,
title={Bone density, microarchitecture, and tissue quality after long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine},
author={G{\"u}erri-Fern{\'a}ndez, Robert and Molina-Morant, Daniel and Villar-Garc{\'\i}a, Judit and Herrera, Sabina and Gonz{\'a}lez-Mena, Alicia and Guelar, Ana and Trenchs-Rodr{\'\i}guez, Marta and D{\'\i}ez-P{\'e}rez, Adolfo and Knobel, Hernando},
journal={JAIDS Journal of Acquired Immune Deficiency Syndromes},
volume={75},
number={3},
pages={322--327},
year={2017},
publisher={LWW}
}
Downloads: 0
{"_id":"Gx4APHBfgJEuiPR8g","bibbaseid":"gerrifernndez-molinamorant-villargarca-herrera-gonzlezmena-guelar-trenchsrodrguez-dezprez-etal-bonedensitymicroarchitectureandtissuequalityafterlongtermtreatmentwithtenofoviremtricitabineorabacavirlamivudine-2017","author_short":["Güerri-Fernández, R.","Molina-Morant, D.","Villar-Garcı́a, Judit","Herrera, S.","González-Mena, A.","Guelar, A.","Trenchs-Rodrı́guez, Marta","Dı́ez-Pérez, Adolfo","Knobel, H."],"bibdata":{"bibtype":"article","type":"article","title":"Bone density, microarchitecture, and tissue quality after long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine","author":[{"propositions":[],"lastnames":["Güerri-Fernández"],"firstnames":["Robert"],"suffixes":[]},{"propositions":[],"lastnames":["Molina-Morant"],"firstnames":["Daniel"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Villar-Garcı́a, Judit"],"suffixes":[]},{"propositions":[],"lastnames":["Herrera"],"firstnames":["Sabina"],"suffixes":[]},{"propositions":[],"lastnames":["González-Mena"],"firstnames":["Alicia"],"suffixes":[]},{"propositions":[],"lastnames":["Guelar"],"firstnames":["Ana"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Trenchs-Rodrı́guez, Marta"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dı́ez-Pérez, Adolfo"],"suffixes":[]},{"propositions":[],"lastnames":["Knobel"],"firstnames":["Hernando"],"suffixes":[]}],"journal":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":"75","number":"3","pages":"322–327","year":"2017","publisher":"LWW","bibtex":"@article{guerri2017bone,\n title={Bone density, microarchitecture, and tissue quality after long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine},\n author={G{\\\"u}erri-Fern{\\'a}ndez, Robert and Molina-Morant, Daniel and Villar-Garc{\\'\\i}a, Judit and Herrera, Sabina and Gonz{\\'a}lez-Mena, Alicia and Guelar, Ana and Trenchs-Rodr{\\'\\i}guez, Marta and D{\\'\\i}ez-P{\\'e}rez, Adolfo and Knobel, Hernando},\n journal={JAIDS Journal of Acquired Immune Deficiency Syndromes},\n volume={75},\n number={3},\n pages={322--327},\n year={2017},\n publisher={LWW}\n}\n\n","author_short":["Güerri-Fernández, R.","Molina-Morant, D.","Villar-Garcı́a, Judit","Herrera, S.","González-Mena, A.","Guelar, A.","Trenchs-Rodrı́guez, Marta","Dı́ez-Pérez, Adolfo","Knobel, H."],"key":"guerri2017bone","id":"guerri2017bone","bibbaseid":"gerrifernndez-molinamorant-villargarca-herrera-gonzlezmena-guelar-trenchsrodrguez-dezprez-etal-bonedensitymicroarchitectureandtissuequalityafterlongtermtreatmentwithtenofoviremtricitabineorabacavirlamivudine-2017","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/JjDrfcx9HqWTvtTfZ","dataSources":["xMBki24qbZ8GTMR6r"],"keywords":[],"search_terms":["bone","density","microarchitecture","tissue","quality","long","term","treatment","tenofovir","emtricitabine","abacavir","lamivudine","güerri-fernández","molina-morant","villar-garcı́a","herrera","gonzález-mena","guelar","trenchs-rodrı́guez","dı́ez-pérez","knobel"],"title":"Bone density, microarchitecture, and tissue quality after long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine","year":2017}